Gzor M Forte 1mg/1000mg Tablet is a combination oral hypoglycemic agent containing Glimepiride 1mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, stimulates pancreatic beta cells to release insulin, thereby reducing blood glucose levels. Metformin, a biguanide, primarily decreases hepatic glucose production and improves peripheral insulin sensitivity, enhancing glucose uptake by muscle tissues. This dual mechanism provides effective glycemic control in patients inadequately managed by diet, exercise, and monotherapy. Gzor M Forte is typically prescribed when monotherapy with either agent is insufficient to achieve target glycemic levels. It should be used alongside lifestyle modifications including diet and exercise. The medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, severe renal or hepatic impairment, and conditions predisposing to hypoxia. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and risk of hypoglycemia due to Glimepiride. Regular monitoring of blood glucose, renal function, and periodic assessment for lactic acidosis symptoms is recommended. Dose adjustments may be necessary based on therapeutic response and tolerability. Gzor M Forte should be administered under medical supervision to optimize diabetes management and minimize complications.

Dosage & How to Use